MelbyJC. Systematic corticosteroid therapy: Pharmacology and endocrinologic considerations. Ann Intern Med1974; 81: 505–12.
3.
KozowerMVeatchLKaplanMM. Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J Clin Endocrinol Metab1974; 38: 407–12.
4.
GambertoglioJGVincentiFFeduskaNJBirnbaumJSalvatierraOJrAmendWJCJr. Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients. J Clin Endocrinol Metab1980; 51: 561.
5.
GuglerRShoemanDWHuffmanDHCohlmiaJBAzarnoffDL. Pharmacokinetics of drugs in patients with the nephrotic syndrome. J Clin Invest1975; 55: 1182–9.
6.
LewisGPJuskoWJBurkeCWGravesL. Prednisone side-effects and serum-protein levels. A collaborative study. Lancet1971; 2: 778–81.
7.
SlaunwhiteWRLockieGNBackNSandbergAA. Inactivity in vivo of transcortin-bound Cortisol. Science1962; 135: 1062–3.
8.
LeglerUFFreyFJBenetLZ. Prednisolone clearance at steady-state in humans. J Clin Endocrinol Metab1982: in press.
9.
MoelDIKwunYA. Adrenal function in steroid treated minimal change nephrotic syndrome. Kidney Int1978; 14: 656.
10.
LeistiSKoskimiesORapolaJHallmanNPerheentupaJVilskaJ. Association of post medication hypocortisolism with early first relapse of idiopathic nephrotic syndrome. Lancet1977; 2: 795–6.
11.
FreyFJFreyBMBenetLZ. Steroids. In: MartonLJKabraPM, eds. Liquid chromatography in clinical analysis. Clifton, NJ: The Humana Press, 1981: 307–22.
12.
FreyFJAmendWJCLozadaFFreyBMBenetLZ. Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone. J Clin Endocrinol Metab1981; 53: 1076–80.
13.
FreyFJAmendWJCLozadaFFreyBMHolfordNHGBenetLZ. Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and noncushingoid patients. Eur J Clin Pharmacol1981; 21: 235–42.
14.
FreyFJFreyBMBenetLZ. Liquid chromatographic measurement of endogenous and exogenous glucocorticoids in plasma. Clin Chem1979; 25: 1944–8.
15.
FreyFJFreyBMGreitherABenetLZ. Prednisolone clearance at steady-state in dogs. J Pharmacol Exp Ther1980; 215: 287–91.
16.
BehmHLWagnerJG. Errors in interpretation of data from equilibrium dialysis protein binding experiments. Res Commun Chem Pathol Pharmacol1979; 26: 145–60.
17.
FreyBMMordasiniRFreyFJWegmuellerESchlierfGHodlerJ. Dysproteinemia during total fasting. Metabolism1979; 28: 363–8.
18.
GibaldiMPerrierD. Pharmacokinetics. New York: Marcel Dekker, 1975: 293–6.
19.
BenetLZGaleazziRL. Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci1979; 68: 1071–4.
Normal reference laboratory values. N Engl J Med1980; 302: 37–48.
22.
RoseJQYurchackAMJuskoWJ. Dose-dependent pharmacokinetics of prednisone and prednisolone in man. J Pharmacokinet Biopharm1981; 9: 407–35.
23.
FreyFJLozadaFGuentertTFreyBM. A single dose of azathioprine does not affect the pharmacokinetics of prednisolone following oral prednisone. Eur J Clin Pharmacol1981; 19: 209–12.
24.
De MoorePDeckxRSteenoO. Influence of various steroids on the specific binding of Cortisol. J Endocrinol1963; 27: 355–6.
